Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flavie Luciani

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Nature|June 11, 2025
Targeting GRPR for sex hormone-dependent cancer after loss of E-cadherinJérémy H Raymond, Zackie Aktary, Marie Pouteaux, et al.
Nature|July 14, 2025
Publisher Correction: Targeting GRPR for sex hormone-dependent cancer after loss of E-cadherinJérémy H Raymond, Zackie Aktary, Marie Pouteaux, et al.
Nature Communications|April 14, 2015
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell stateAnnelien Verfaillie, Hana Imrichova, Zeynep Kalender Atak, et al.
The Journal of Clinical Investigation|May 3, 2017
Comparative oncogenomics identifies tyrosine kinase FES as a tumor suppressor in melanomaMichael Olvedy, Julie C Tisserand, Flavie Luciani, et al.
Nature Medicine|July 24, 2012
MDM4 is a key therapeutic target in cutaneous melanomaAgnieszka Gembarska, Flavie Luciani, Clare Fedele, et al.
Journal of the National Cancer Institute|July 28, 2010
GLI2-mediated melanoma invasion and metastasisVasileia-Ismini Alexaki, Delphine Javelaud, Leon C L Van Kempen, et al.
Cell Death & Disease|November 17, 2017
The fragile X mental retardation protein regulates tumor invasiveness-related pathways in melanoma cellsFrancesca Zalfa, Vincenzo Panasiti, Simone Carotti, et al.
Journal of the National Cancer Institute|April 5, 2017
Deciphering the Role of Oncogenic MITFE318K in Senescence Delay and Melanoma ProgressionCaroline Bonet, Flavie Luciani, Jean-François Ottavi, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Nature|June 11, 2025
Targeting GRPR for sex hormone-dependent cancer after loss of E-cadherinJérémy H Raymond, Zackie Aktary, Marie Pouteaux, et al.
Nature|July 14, 2025
Publisher Correction: Targeting GRPR for sex hormone-dependent cancer after loss of E-cadherinJérémy H Raymond, Zackie Aktary, Marie Pouteaux, et al.
Nature Communications|April 14, 2015
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell stateAnnelien Verfaillie, Hana Imrichova, Zeynep Kalender Atak, et al.
The Journal of Clinical Investigation|May 3, 2017
Comparative oncogenomics identifies tyrosine kinase FES as a tumor suppressor in melanomaMichael Olvedy, Julie C Tisserand, Flavie Luciani, et al.
Nature Medicine|July 24, 2012
MDM4 is a key therapeutic target in cutaneous melanomaAgnieszka Gembarska, Flavie Luciani, Clare Fedele, et al.
Journal of the National Cancer Institute|July 28, 2010
GLI2-mediated melanoma invasion and metastasisVasileia-Ismini Alexaki, Delphine Javelaud, Leon C L Van Kempen, et al.
Cell Death & Disease|November 17, 2017
The fragile X mental retardation protein regulates tumor invasiveness-related pathways in melanoma cellsFrancesca Zalfa, Vincenzo Panasiti, Simone Carotti, et al.
Journal of the National Cancer Institute|April 5, 2017
Deciphering the Role of Oncogenic MITFE318K in Senescence Delay and Melanoma ProgressionCaroline Bonet, Flavie Luciani, Jean-François Ottavi, et al.
Pageof 2